JVT has changed the sentiment on SNG?25 Jan 2022 10:29
I think it has with regards to bang for buck and timing. Seems like that the market size is indeed much smaller than anticipated and will not be handed out as first line therapy to all even on oxygen if it passes P3 and is approved. Not everyone on oxygen will further deteriorate in so far as to need this, most do indeed recover with existing treatments. There may even be some delay in approval, allowing them time to work out the cohort that will actually benefit that provides value for money.
Add this on top of post omicron western world when demand will be severely reduced for SNG. There is no point comparing this with other treatments, they got lucky due to timing. SNG is coming far too late to the party, just as its about to end.